In the present study, we sought to develop a risk for recurrence score (RRS) based on three proliferation markers, e.g. RACGAP1, TOP2A and Ki67, in high-risk early breast cancer patients and evaluate its ability to predict risk for relapse and death. The gene discussed is RACGAP1; the disease is breast cancer.